Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
04/2012
04/10/2012US8153655 Compositions useful as inhibitors of voltage-gated sodium channels
04/05/2012WO2012020131A3 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
04/05/2012US20120083603 High stability polyionic liquid salts
04/05/2012US20120083602 Benzamides and related inhibitors of factor xa
04/05/2012US20120083471 Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same
04/05/2012US20120082646 Antiviral Compounds And Uses Thereof
04/04/2012EP1960343B1 Indene derivatives, their preparation and use as medicaments
04/04/2012CN102405209A Diacylethylenediamine compound
04/04/2012CN102405189A Fluorosulfonyl imide salt and method for producing fluorosulfonyl imide salt
04/03/2012US8148443 Oxonium and sulfonium salts
04/03/2012US8148422 Sulfonamides as TRPM8 modulators
04/03/2012CA2593010C Process for the preparation of tamsulosin and intermediates thereof
04/03/2012CA2423744C Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
03/2012
03/29/2012WO2012039025A1 Process for producing perfluoroalkylsulfonamide
03/29/2012WO2011149213A3 Novel derivative having inhibitory activity against 11β-hsd1, preparation method thereof, and pharmaceutical composition containing same as active ingredient
03/29/2012WO2011071951A3 N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
03/29/2012WO2011071947A3 Bis-acylated hydroxylamine derivatives
03/29/2012US20120077976 Camphor-derived compounds, method for manufacturing the same, and application thereof
03/29/2012US20120077973 Sulphonylated Diphenylethylenediamines, Method for Their Preparation and Use in Transfer Hydrogenation Catalysis
03/29/2012US20120077838 Beta-2-Adrenoreceptor Agonists
03/29/2012US20120077796 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
03/28/2012EP2432556A1 Protease inhibitors
03/28/2012CN102395558A Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
03/28/2012CN102395427A Process for hydrogenating a substrate having ru(ii)
03/28/2012CN102391061A Method for preparing diaryl amine compound from 3-methyl dehydroshikimate
03/28/2012CN102389745A Preparation method of fluorine-containing double-type cationic surfactant and use thereof
03/28/2012CN101084178B (benzyloxy-biphenyl) acetic acids and derivatives thereof
03/22/2012WO2012035171A2 New compounds
03/22/2012US20120071689 Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foam stabilizers
03/22/2012US20120071640 Sulfurizing reagents and their use for oligonucleotides synthesis
03/22/2012US20120071626 Fluorinated aromatic bis(acyl)-containing compounds and polyesters prepared therefrom
03/21/2012CN1984883B Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
03/21/2012CN1441770B Modified forms of pharmacologically active agents and uses therefor
03/21/2012CN102382018A Preparation process of sulfonyl amino-benzene hydrazine
03/21/2012CN102382010A Preparation process for 4- bromo phenyl hydrazine
03/21/2012CN101039900B 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
03/20/2012US8138218 Growth hormone secretagogues
03/20/2012CA2507765C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
03/15/2012WO2012031993A1 Novel n-hydroxy-benzamides for the treatment of cancer
03/15/2012US20120065270 Potassium ion channel modulators and uses thereof
03/15/2012US20120064062 Inhibitors of bacterial plasminogen activators
03/15/2012US20120064060 Compound having s1p receptor binding potency and use thereof
03/15/2012US20120061325 Chelating compounds and immobilized tethered chelators
03/15/2012CA2809736A1 N-hydroxy-benzamides for the treatment of cancer
03/14/2012EP2427425A2 Tetracycline compounds
03/14/2012CN102372713A Dual alanyl-aminopeptidase and dipeptidyl-peptidase iv inhibitors
03/13/2012CA2643097C Amine derivatives
03/13/2012CA2528174C Process for the preparation of cpla2 inhibitors
03/13/2012CA2369074C Ether compounds, compositions, and uses thereof
03/08/2012WO2012029672A1 Noxious organism control agent
03/08/2012WO2012027951A1 An intermediate used for preparation of imipenem medicine, a preparation method and use thereof
03/08/2012WO2012007877A3 N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
03/08/2012WO2012007868A3 N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
03/08/2012US20120059055 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
03/08/2012CA2808144A1 Pest control agent
03/07/2012EP1347938B1 Method for fluorinating a compound comprising a halosulphonyl or dihalophosphonyl group
03/06/2012US8129406 Nonpeptide inhibitors of matrix metalloproteinases
03/06/2012US8129355 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/06/2012CA2348998C Lipoic acid derivatives and their use in treatment of disease
03/01/2012WO2012027717A2 Flourescence labeling reagents and uses thereof
03/01/2012WO2012027482A2 Compounds, compositions and methods related to ppar antagonists
03/01/2012US20120053300 Functionalized polysulfide silica coupling agents and silica reinforced rubber composition for tire components
03/01/2012US20120053243 Parakeratosis inhibitor and skin preparation for external use
02/2012
02/29/2012EP2421829A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
02/29/2012EP1606248B1 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
02/29/2012CN102365266A Fluorine-containing n-alkyl sulfonyl imide compound, manufacturing method therefor, and method of manufacturing an ionic compound
02/29/2012CN102365265A Indane derivatives
02/28/2012US8124630 ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
02/23/2012WO2012021963A1 Novel sulfonamide compounds for inhibition of metastatic tumor growth
02/23/2012CA2841217A1 Novel sulfonamide compounds for inhibition of metastatic tumor growth
02/22/2012EP2419401A2 GAMMA-AMINO-BUTYRIC ACID DERIVATIVES AS GABAb RECEPTOR LIGANDS
02/22/2012EP0986384B1 Inhibitors of protein isoprenyl transferases
02/22/2012CN102361853A Toluidine sulfonamides and their use
02/21/2012US8119685 Disubstituted aniline compounds
02/21/2012CA2659184C Ep2 agonists
02/21/2012CA2348704C Sulphonylation method and reagent useful for perhalogenated sulphanilide synthesis
02/16/2012WO2012021486A2 Acylsulfonamides and processes for producing the same
02/16/2012WO2012020513A1 Method for producing fluorine-containing sulfonylimide compound
02/16/2012WO2012020133A1 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012WO2012020130A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012US20120040948 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012US20120040947 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012CA2848342A1 Acylsulfonamides and processes for producing the same
02/16/2012CA2806658A1 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012CA2806644A1 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012CA2806643A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
02/15/2012EP2417102A2 Fluorophore and fluorescent sensor compound containing same
02/15/2012EP2417101A1 Indane derivatives
02/15/2012EP1963259B1 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
02/15/2012EP1735268B1 Opioid receptor antagonists
02/15/2012CN102351755A Fluorine-containing imine cationic surfactant preparation method and application thereof
02/15/2012CN102351754A Method for preparing 4-amino-N-methylphenyl methane sulfonamide
02/15/2012CN102351753A Fluorine-containing Gemini-like anionic surface active agent, its preparation method and its application
02/15/2012CN102351621A Method for preparing N-sulfonyl amidine
02/14/2012US8115027 NPY Y5 antagonist
02/14/2012CA2416995C Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation
02/09/2012WO2012018635A2 Arylsulfonamide derivatives, compositions, and methods of use
02/09/2012WO2012017166A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
02/09/2012US20120035328 Methods for forming dyed microspheres and populations of dyed microspheres
02/09/2012US20120035179 Modulators of atp-binding cassette transporters
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 177